Observational studyPloS one2025
Fatigue and neuromuscular function in long COVID: A one-year follow-up study.
Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04961255 (Effects of Post-COVID-19 on Neural Activation and Architecture of the Quadriceps Femoral Muscle-tendon Unit and Its Correlation With Inflammatory Markers), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Post-COVID-19 on Neural Activation and Architecture of the Quadriceps Femoral Muscle-tendon Unit and Its Correlation With Inflammatory Markers
Who cites it
3 citing papers in PubMed.
- Article
- Persistent impairments in muscle function and symptom burden in post-COVID syndrome: a prospective longitudinal study.Journal of translational medicine · 2026Observational
- A Prospective Cohort Longitudinal Study of Human Acute Babesiosis: Quality of Life and Severity of Symptoms Through 1-Year Follow-up.Open forum infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong COVID has emerged as a significant complication of SARS-CoV-2 infection. However, the long-term neuromuscular consequences of this condition, particularly one-year post-infection, remain poorly understood. This study aimed to determine the mechanisms of fatigue by comparing perceived fatigue, objective fatigability, functionality, muscle architecture, and electrical neuromuscular function in participants who had suffered severe or moderate COVID‑19 one-year post-infection with a healthy control group. METHODS AND
findingsThis longitudinal observational study followed participants for one-year. The assessments were conducted at the Laboratory of Muscle and Tendon Plasticity at the University of Brasília, Brazil. Participants who had suffered moderate or severe SARS-CoV-2 infection were compared to a control group. A baseline assessment was initially conducted (21-30 days post-symptoms onset or post-hospital discharge), followed by second (31-90), third (91-180), and fourth (181-360) assessments. Perceived fatigue, objective fatigability, functionality, muscle architecture, and electrical neuromuscular function were analyzed. The study included 30 controls (46.53 [42.10-51.43] years; 13 men [43.33%]), 22 moderate cases (38.27 [33.96-43.13] years; 10 men [45.45%]), and 18 severe cases (50.83 [45.19-57.18] years; eight men [44.44%]). Severe participants exhibited higher perceived fatigue in all assessments than the control group and at baseline and in assessment 4 compared to moderate cases, in addition to a lower torque and torque-time integral in all assessments of objective fatigability analysis compared to the other groups. The severe group also demonstrated reduced functionality, impaired muscle architecture (characterized by increased echogenicity), and higher chronaxie values in the electrical neuromuscular function assessment. Participants with moderate COVID‑19 exhibited alterations in perceived fatigue, reduced torque, and lower TTI, electrical neuromuscular function, and muscle architecture, particularly at baseline.
conclusionsSevere participants continued to experience significant perceived fatigue even one-year post-infection, suggesting a slower recovery trajectory, that contributed to increased fatigability throughout the follow-up period. These results emphasize the role of musculoskeletal and neural mechanisms in post-COVID‑19 fatigue, highlighting the need for targeted, mechanism-based rehabilitation strategies.
trial registrationNCT04961255.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.